References
- Almeida GM, Duarte TL, Steward WP, Jones GDD. (2006). Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay. DNA Repair 5:219–225.
- Ang WH, Myint M, Lippard SJ. (2010). Transcription Inhibition by Platinum-DNA Cross-Links in Live Mammalian Cells. J Am Chem Soc 132:7429–7435.
- Boisdron-Celle M, Lebouil A, Allain P, Gamelin E. (2001). Pharmacokinetic properties of platinum derivatives. Bull Cancer 88:S14–S19.
- Burgos L, Lehmann M, de Andrade HHR, et al. (2014). In vivo and in vitro genotoxicity assessment of 2-methylisoborneol, causal agent of earthy-musty taste and odor in water. Ecotoxicol Environ Saf 100:282–286.
- Cid MG, Mudry M, Larripa I. (1995). Chromosome-damage induced by carboplatin (CBDCA). Toxicol Lett 76:97–103.
- Danesi CC, Bellagamba BC, Dihl RR, et al. (2010). Evaluation of the genotoxicity of cisplatin, paclitaxel and 5-fluorouracil combined treatment in the Drosophila wing-spot test. Food Chem Toxicol 48:3120–3124.
- Di Francesco AM, Ruggiero A, Riccardi R. (2002). Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci 59:1914–1927.
- Fenech M, Morley A. (1985). Solutions to the kinetic problem in the micronucleus assay. Cytobios 43:233–246.
- Fenech M. (2006). Cytokinesis-block micronucleus assay evolves into a cytome assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 600:58–66.
- Fenech M. (2007). Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104.
- Gebel T, Lantzsch H, Plessow K, Dunkelberg H. (1997). Genotoxicity of platinum and palladium compounds in human and bacterial cells. Mutat Res 389:183–190.
- Jacociunas LV, Andrade HHR, Lehmann M, Abreu BRR, et al. (2013). Artichoke induces genetic toxicity in the cytokinesis-block micronucleus (CBMN) cytome assay. Food Chem Toxicol 55:56–59.
- Jung Y, Lippard SJ. (2007). Direct cellular responses to platinum-induced DNA damage. Chem Rev 107:1387–1407.
- Mahmoodi M, Soleyman-Jahi S, Zendehdel K, et al. (2016). Chromosomal aberrations, sister chromatid exchanges and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs. Drug Chem Toxicol. In press. http://dx.doi.org/10.1080/01480545.2016.1209678.
- Nersesyan A, Perrone E, Roggieri P, Bolognesi C. (2006). Cytogenetic toxicity of cycloplatam in human lymphocytes: detection by the micronucleus test and fluorescence in situ hybridization. Anticancer Drugs 17:289–295.
- OECD. (2014). Test No. 473: in vitro mammalian cell micronucleus test. OECD guidelines for testing of chemicals, Section 4: health effects. Paris: OECD Publishing.
- Overbeck TL, Knight JM, Beck DJ. (1996). A comparison of the genotoxic effects of carboplatin and cisplatin in Escherichia coli. Mutat Res 362:249–259.
- Pang SK, Yu CW, Au-Yeaung SC, Ho YP. (2007). DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes. Biochem Biophys Res Commun 363:235–240.
- Peres LAB, Junior ADC. (2013). Acute nephrotoxicity of cisplatin: molecular mechanisms. J Bras Nefrol 35:332–340.
- Qu K, Lin T, Wang Z, et al. (2014). Reactive oxygen species generation is essential for cisplatin induced accelerated senescence in hepatocellular carcinoma. Front Med 8:227–235.
- Riccardi R, Riccardi A, Di Rocco C, et al. (1992). Cerebrospinal fluid pharmacokinetics of carboplatin in children with brain tumors. Cancer Chemother Pharmacol 30:21–24.
- Shimizu N, Itoh N, Utiyama H, Wahl GM. (1998). Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S phase. J Cell Biol 140:1307–1320.
- Shinkai T, Saijo N, Eguchi K. (1988). Cytogenetic effect of carboplatin on human lymphocytes. Cancer Chemother Pharmacol 21:203–207.
- Silveira JF. (2013). Modulação dos efeitos citotóxicos, genotóxico e mutagênico do 5-Fluoracil e oxaliplatina pelo tratamento com selenocistina na linhagem celular de adenocarcinoma de mama humano MCF-7 [Master thesis]. Rio Grande do Sul, Brazil: Lutheran University of Brazil.